GMED Classe A Globus Medical, Inc. Class A Common Stock
NYSE · Health Care · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 6, 2026
$75,60
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$56,50mínima 52 sem
$101,40máxima 52 sem
P/E (TTM)
19.4
EPS (TTM)
$3.89
Receita (TTM)
$3.14B
seus distintivos
Intervalo 52 Semanas
$56–$101
Classificação do Analista
BUY
Preço-Alvo
$101
P/E
19.4
ROE
11.8%
Margem de Lucro Líquido
17.0%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
GMED Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$75.60
P/E (TTM)
19.4
EPS (TTM)
$3.89
Receita (TTM)
$3.14B
ROE (TTM)
11.8%
Intervalo 52 Semanas
$57–$101
GMED Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Sobre Globus Medical, Inc. Class A Common Stock Visão geral da empresa da Wikipedia
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
Products
Globus develops, manufactures, and markets orthopedic implants including spine, trauma, and artificial joints.
Globus Medical makes the ExcelsiusGPS surgical robotic system for spine surgery. The robot is used for transpedicular drilling and screw placement. In November 2024, the company launched its ExcesiusHub, an advanced surgical navigation system for robotic surgical procedures.
The ADIRA XLIF Plate System aids in enhancing lateral spine surgery procedures.
Acquisitions
In January 2014, Globus Medical acquired Excelsius Surgical. The Excelsius system is designed to integrate intra-operative digital imaging with a robotic surgery device to hold patients in place during surgeries "with sub-millimeter accuracy". In October of that year, the company acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). TTOT provides human tissue products, including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.
In February 2015, Globus Medical acquired Branch Medical Group, a third-party manufacturer of high-precision medical devices.
In July 2016, Globus Medical acquired Alphatec Holdings, an international operations and distribution channel, for $80 million. As part of the transaction, Globus has agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.
In September 2018, Globus Medical acquired Nemaris, developers of Surgimap, a pre-operative planning software for spinal surgeons.
In August 2019, Globus Medical acquired privately owned StelKast, manufacturer of implants and instruments for hip and knee replacement.
In February 2023, Globus Medical acquired NuVasive in an all-stock deal valued at $3.1 billion.
Controversies
In August 2007 Globus Medical settled a lawsuit initially filed by Synthes in 2004 over alleged stolen trade secrets. Former Synthes employees, who then worked for Globus, were accused of stealing 2300 electronic files containing blueprints for Synthes' products, safety-testing plans, and verbatim 510(k) filing documents. Globus paid Synthes $13.5 million and did not admit any wrongdoing.
In 2011, Synthes filed a second lawsuit against Globus Medical for infringing three patents, "asking the court to force the defendant to destroy its allegedly infringing products." Orthopedic Design & Technology Magazine reports that, "There was no finding of willful infringement in this lawsuit." A $16 million monetary damage was paid by Globus Medical in 2013.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
setorHealth Care
indústriaHealth Care
funcionários6.000
paísUS
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$2.94B2016-12-31 → 2025-12-31
EPS$3.922016-12-31 → 2025-12-31
Fluxo de caixa livre$589M2016-12-31 → 2025-12-31
Margem líquida17.0%2016-12-31 → 2025-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | GMED | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | 19.4média 5A ≈54.5 | ≈54.5 | 28.6 | Subvalorizado | |
| PEG Ratio | ≈0.6 | · | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | GMED | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Operacional (TTM) | 20.3%média 5A ≈12.3% | ≈12.3% | 13.1% | Primeira linha | |
| Margem EBITDA (TTM) | 29.2%média 5A ≈21.3% | ≈21.3% | 13.7% | Primeira linha | |
| Margem de Impostos Pré-Tributação (TTM) | 21.0%média 5A ≈13.7% | ≈13.7% | 11.8% | Primeira linha | |
| Margem de Lucro Líquido (TTM) | 17.0%média 5A ≈11.4% | ≈11.4% | 9.0% | Primeira linha | |
| ROA (TTM) | 10.2%média 5A ≈6.0% | ≈6.0% | 4.6% | Primeira linha | |
| ROE (TTM) | 11.8%média 5A ≈6.6% | ≈6.6% | 8.9% | Primeira linha | |
| ROIC | 9.3%média 5A ≈5.8% | ≈5.8% | 7.1% | Primeira linha |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | GMED | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Índice de liquidez corrente (MRQ) | 4.6média 5A ≈4.5 | ≈4.5 | 2.4 | Liquidez forte | |
| Índice de Liquidez Seca (MRQ) | 2.7média 5A ≈1.9 | ≈1.9 | 1.0 | Liquidez forte |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | GMED | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 16.7%média 5A ≈31.8% | ≈31.8% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 42.2%média 5A ≈35.3% | ≈35.3% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 30.1% | · | · | · | |
| EPS YoY | 422.7%média 5A ≈84.3% | ≈84.3% | · | · | |
| Net Income YoY (Lucro Líquido Ano a Ano) | 422.3%média 5A ≈88.8% | ≈88.8% | · | · | |
| EPS CAGR 3Y (CAGR de LPA 3A) | 28.4%média 5A ≈3.6% | ≈3.6% | · | · | |
| EPS CAGR 5Y (CAGR de LPA 5A) | 31.2% | · | · | · | |
| Net Income CAGR 3Y (CAGR de Lucro Líquido 3A) | 41.4%média 5A ≈12.0% | ≈12.0% | · | · | |
| Net Income CAGR 5Y (CAGR de Lucro Líquido 5A) | 39.4% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | GMED | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.6média 5A ≈0.5 | ≈0.5 | 0.5 | Em linha | |
| Inventory Turnover (Giro de Estoque) | 1.4média 5A ≈1.2 | ≈1.2 | 1.8 | Fraco | |
| Receivables Turnover (Giro de Contas a Receber) | 4.8média 5A ≈5.0 | ≈5.0 | 6.2 | Fraco | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$489.8K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
16.2%
Próximo relatório
Nov 04, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 5, 2026 | $1.34 | $1.12 | 19.5% |
| 31 de Março de 2026 | Mai 12, 2026 | $1.12 | $0.94 | 19.4% |
| 31 de Dezembro de 2025 | $1.28 | $1.17 | 9.2% | |
| 30 de Setembro de 2025 | $1.18 | $0.80 | 47.8% | |
| 30 de Junho de 2025 | $0.86 | $0.77 | 11.6% | |
| 31 de Março de 2025 | $0.68 | $0.76 | -10.4% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Cost of Revenue | $958M | $1.04B | $548M | $264M | $239M | $217M | $180M | $159M | $150M | $135M | $132M | $111M | |
| Gross Profit | · | · | $1.02B | $759M | $719M | $572M | $605M | $554M | $486M | $429M | $412M | $364M | |
| R&D Expense | $147M | $164M | $124M | $73M | $97M | $85M | $60M | $55M | $44M | $45M | $36M | $31M | |
| SG&A Expense | $1.18B | $981M | $644M | $432M | $408M | $355M | $355M | $312M | $268M | $222M | $210M | $189M | |
| Operating Expenses | · | · | $887M | $531M | $547M | $460M | $433M | $384M | $324M | $275M | $240M | $225M | |
| Operating Income | $480M | $166M | $133M | $228M | $172M | $111M | $172M | $169M | $162M | $154M | $172M | $138M | |
| Other Non-op | $3M | $2M | $-2M | $2M | $8M | $14M | $18M | $19M | $8M | $3M | $583.0K | $280.0K | |
| Pretax Income | $605M | $121M | $165M | $243M | $180M | $126M | $190M | $189M | $170M | $157M | $173M | $139M | |
| Income Tax | $67M | $18M | $43M | $53M | $31M | $24M | $35M | $32M | $63M | $53M | $60M | $46M | |
| Net Income | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| EPS (Basic) | $3.98 | $0.76 | $1.09 | $1.89 | $1.48 | $1.04 | $1.57 | $1.60 | $1.12 | $1.09 | $1.19 | $0.98 | |
| EPS (Diluted) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 | |
| Shares (Basic) | 135,215,000 | 135,726,000 | 113,087,000 | 100,469,000 | 100,734,000 | 98,580,000 | 99,150,000 | 97,884,000 | 96,243,000 | 95,647,000 | 95,046,000 | 94,227,000 | |
| Shares (Diluted) | 137,056,000 | 137,863,000 | 114,630,000 | 102,643,000 | 103,623,000 | 100,971,000 | 101,998,000 | 101,316,000 | 97,887,000 | 96,432,000 | 96,073,000 | 95,457,000 | |
| EBITDA | $757M | $420M | $278M | · | $242M | $174M | $225M | $211M | $204M | $193M | $196M | $160M |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $526M | $784M | · | · | · | · | $195M | $140M | $119M | $67M | $58M | $82M | |
| Short-term Investments | $31M | $106M | $50M | $296M | $250M | $187M | · | $200M | $255M | $223M | $221M | $146M | |
| Receivables | $679M | $558M | $503M | $213M | $164M | $142M | $154M | $137M | $117M | $92M | $78M | $75M | |
| Inventory | $759M | $659M | $848M | $299M | $237M | $229M | $196M | $131M | $108M | $113M | $105M | $91M | |
| Prepaid Expense | $65M | $50M | $45M | $21M | $18M | $18M | $17M | $15M | $11M | $15M | $7M | $6M | |
| Current Assets | $2.13B | $2.18B | $1.92B | $983M | $865M | $822M | $687M | $631M | $620M | $514M | $545M | $470M | |
| PP&E (Net) | $564M | $562M | $587M | $244M | $221M | $217M | $200M | $172M | $143M | $124M | $115M | $69M | |
| PP&E (Gross) | $1.27B | $1.11B | $1.01B | $587M | $527M | $493M | $444M | $389M | $335M | $291M | $254M | $188M | |
| Accum. Depreciation | $705M | $546M | $426M | $343M | $306M | $276M | $244M | $217M | $192M | $167M | $139M | $119M | |
| Goodwill | $1.44B | $1.43B | $1.43B | $197M | $180M | $157M | $129M | $124M | $124M | $106M | $92M | $53M | |
| Intangibles | $745M | $795M | $925M | $64M | $69M | $87M | $79M | $87M | $79M | $62M | $33M | $35M | |
| Other Non-current Assets | $79M | $75M | $79M | $37M | $36M | $32M | $22M | $10M | $8M | $928.0K | $590.0K | $975.0K | |
| Total Assets | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Accounts Payable | $99M | $75M | $57M | $36M | $22M | $18M | $25M | $26M | $25M | $17M | $16M | $16M | |
| Accrued Liabilities | $334M | $261M | $240M | $92M | $91M | $78M | $63M | $60M | $53M | $46M | $54M | $61M | |
| Current Liabilities | $498M | $856M | $392M | $159M | $140M | $121M | $111M | $96M | $93M | $80M | $83M | $89M | |
| Capital Leases | $104M | $84M | $91M | $3M | $3M | $3M | $1M | · | · | · | · | · | |
| Deferred Tax | · | $24M | $84M | $2M | $4M | $6M | $6M | $8M | $11M | $8M | $13M | $5M | |
| Other Non-current Liabilities | $21M | $22M | $25M | $10M | $13M | $15M | $9M | $8M | $2M | $2M | $2M | $3M | |
| Total Liabilities | $730M | $1.07B | $1.09B | $230M | $216M | $173M | $130M | $115M | $111M | $96M | $119M | $118M | |
| Paid-in Capital | $3.17B | $3.03B | $2.87B | $631M | $554M | $457M | $357M | $300M | $238M | $212M | $193M | $175M | |
| Retained Earnings | $1.39B | $1.15B | $1.14B | $1.24B | $1.19B | $1.05B | $1.05B | $893M | $736M | $629M | $525M | $412M | |
| AOCI | $15M | $-7M | $-10M | $-25M | $-7M | $4M | $-3M | $-7M | $-7M | $-9M | $-2M | $-2M | |
| Stockholders' Equity | $4.57B | $4.18B | $4.00B | $1.85B | $1.74B | $1.51B | $1.40B | $1.19B | $968M | $832M | $715M | $585M | |
| Liabilities + Equity | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Shares Outstanding | · | · | · | · | · | · | 99,825,080 | 98,573,354 | 96,657,881 | 95,929,916 | 95,319,722 | 94,705,743 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $277M | $253M | $146M | $68M | $70M | $63M | $53M | $42M | $42M | $39M | $24M | $22M | |
| Stock-based Comp | $50M | $54M | $53M | $33M | $31M | $27M | $26M | $22M | $15M | $11M | $10M | $7M | |
| Deferred Tax | · | $-134M | $-58M | $-22M | $-18M | $-4M | $4M | $971.0K | $8M | $-4M | $6M | $-4M | |
| Amort. of Intangibles | $118M | $119M | $51M | $18M | $19M | $17M | $14M | $10M | $8M | $3M | $2M | $712.0K | |
| Restructuring | · | $30M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-111M | $243M | $-19M | · | $44M | $11M | $-66M | $-39M | $-13M | $22M | $-31M | $-38M | |
| Operating Cash Flow | $753M | $521M | $243M | $178M | $276M | $199M | $172M | $182M | $159M | $148M | $124M | $79M | |
| CapEx | $165M | $115M | $78M | $74M | $57M | $64M | $71M | $60M | $51M | $41M | $51M | $25M | |
| Investing Cash Flow | $-355M | $-176M | $303M | $-110M | $-376M | $-117M | $-140M | $-193M | $-111M | $-163M | $-153M | $-100M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $10M | |
| Stock Repurchased | $300M | $86M | $226M | $144M | · | $105M | · | · | · | · | · | · | |
| Net Stock Activity | $-300M | $-86M | $-226M | · | · | $-105M | · | · | · | · | · | $10M | |
| Financing Cash Flow | $-679M | $-28M | $-232M | $-110M | $54M | $-39M | $24M | $33M | $2M | $470.0K | $4M | $13M | |
| Net Change in Cash | $-258M | $317M | $317M | $-43M | $-46M | $44M | $56M | $21M | $51M | $-16M | $-25M | $-8M | |
| Taxes Paid | $99M | $159M | $101M | $78M | $45M | $25M | $34M | $31M | · | · | · | · | |
| Free Cash Flow | $589M | $405M | $165M | · | $219M | $135M | $101M | $122M | $108M | $131M | $71M | $54M |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 65.0% | · | 75.0% | 72.4% | 77.1% | 77.6% | 76.3% | 76.1% | 75.6% | 76.6% | |
| Operating Margin | 16.3% | 6.6% | 8.5% | · | 17.9% | 14.1% | 21.9% | 23.8% | 25.4% | 27.3% | 31.6% | 29.2% | |
| Net Margin | 18.3% | 4.1% | 7.8% | · | 15.6% | 13.0% | 19.8% | 21.9% | 16.9% | 18.5% | 20.7% | 19.5% | |
| Pretax Margin | 20.6% | 4.8% | 10.5% | · | 18.8% | 16.0% | 24.2% | 26.5% | 26.7% | 27.9% | 31.7% | 29.2% | |
| EBITDA Margin | 25.8% | 16.7% | 17.7% | · | 25.2% | 22.1% | 28.6% | 29.6% | 32.1% | 34.2% | 36.0% | 33.8% | |
| ROA | 10.2% | 2.0% | 3.4% | · | 8.2% | 6.4% | 11.0% | 13.2% | 10.7% | 11.8% | 14.7% | 14.6% | |
| ROE | 12.1% | 2.5% | 3.0% | · | 8.6% | 7.0% | 11.3% | 13.5% | 11.9% | 13.5% | 17.3% | 17.5% | |
| ROIC | 9.3% | 3.4% | 2.5% | · | 8.2% | 6.0% | 10.0% | 11.8% | 10.6% | 12.3% | 15.7% | 15.8% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.5 | 4.9 | · | 6.2 | 6.8 | 6.2 | 6.6 | 6.7 | 6.4 | 6.6 | 5.3 | |
| Quick Ratio | 2.5 | 0.8 | 1.4 | · | 3.0 | 1.2 | 3.1 | 5.0 | 5.3 | 4.8 | 4.3 | 3.4 |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.4 | · | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | |
| Inventory Turnover | 1.4 | 1.4 | 1.0 | · | 1.0 | 1.0 | 1.1 | 1.3 | 1.4 | 1.2 | 1.4 | 1.4 | |
| Receivables Turnover | 4.8 | 4.7 | 4.4 | · | 6.3 | 5.3 | 5.4 | 5.6 | 6.1 | 6.6 | 7.1 | 6.9 |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | $14.05 | $12.03 | $10.01 | $8.67 | $7.50 | $6.18 | |
| Revenue / Share | $21.44 | $18.27 | $13.68 | · | $9.25 | $7.81 | $7.70 | $7.04 | $6.50 | $5.85 | $5.67 | $4.97 | |
| Cash Flow / Share | $5.50 | $3.78 | $2.12 | · | $2.67 | $1.97 | $1.69 | $1.79 | $1.63 | $1.78 | $1.27 | $0.83 | |
| Cash / Share | · | · | · | · | · | · | $1.96 | $1.42 | $1.23 | $1.38 | $0.63 | $0.87 | |
| EPS (TTM) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 16.7% | 60.6% | 53.3% | 6.8% | 21.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 42.2% | 38.0% | 25.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 30.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 422.7% | -29.9% | -42.2% | 28.5% | 42.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 28.4% | -19.5% | 1.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 31.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 422.3% | -16.2% | -35.4% | 27.5% | 45.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 41.4% | -11.6% | 6.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 39.4% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Net Income TTM | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| Market Cap | · | · | · | · | · | · | $5.88B | $4.27B | $3.97B | $2.38B | $2.65B | $2.25B | |
| P/E | 22.3 | 110.3 | 49.8 | 40.1 | 50.1 | 64.6 | 38.7 | 28.1 | 37.4 | 23.0 | 23.8 | 24.5 | |
| P/S | · | · | · | · | · | · | 7.5 | 6.0 | 6.2 | 4.2 | 4.9 | 4.7 | |
| P/B | · | · | · | · | · | · | 4.2 | 3.6 | 4.1 | 2.9 | 3.7 | 3.8 | |
| P / Cash Flow | · | · | · | · | · | · | 34.2 | 23.5 | 24.9 | 13.8 | 21.7 | 28.4 | |
| P / FCF | · | · | · | · | · | · | 58.1 | 35.0 | 36.7 | 18.2 | 37.2 | 41.4 | |
| Earnings Yield | 4.5% | 0.91% | 2.0% | 2.5% | 2.0% | 1.6% | 2.6% | 3.6% | 2.7% | 4.3% | 4.2% | 4.1% |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $790M | $760M | $826M | $769M | $745M | $598M | $657M | $626M | $630M | $607M | $617M | $384M | $292M | $277M | $274M | $254M | |
| Cost of Revenue | $241M | $234M | $261M | $253M | $249M | $195M | $263M | $271M | $260M | $241M | $265M | $135M | $76M | $71M | $71M | $65M | |
| Gross Profit | · | · | · | · | · | · | · | · | $370M | $365M | · | $248M | $215M | $206M | · | $189M | |
| R&D Expense | $36M | $37M | $36M | $38M | $40M | $33M | $33M | $35M | $38M | $57M | $52M | $29M | $21M | $21M | $20M | $19M | |
| SG&A Expense | $287M | $298M | $318M | $314M | $304M | $243M | $253M | $240M | $239M | $249M | $245M | $156M | $120M | $122M | $118M | $107M | |
| Operating Expenses | · | · | · | · | · | · | · | · | $320M | $357M | · | $248M | $149M | $149M | · | $129M | |
| Operating Income | $182M | $150M | $169M | $137M | $76M | $97M | $60M | $48M | $50M | $8M | $10M | $404.0K | $66M | $56M | $54M | $60M | |
| Other Non-op | $1M | $2M | $391.0K | $2M | $772.0K | $713.0K | $1M | $-570.0K | $997.0K | $710.0K | $-17M | $-475.0K | $8M | $7M | $-5M | $2M | |
| Pretax Income | $190M | $157M | $169M | $144M | $188M | $104M | $25M | $57M | $48M | $-9M | $25M | $3M | $75M | $63M | $62M | $61M | |
| Income Tax | $38M | $33M | $29M | $25M | $-15M | $28M | $-2M | $5M | $16M | $-1M | $10M | $2M | $17M | $14M | $12M | $14M | |
| Net Income | $152M | $124M | $141M | $119M | $203M | $75M | $27M | $52M | $32M | $-7M | $15M | $998.0K | $58M | $49M | $50M | $47M | |
| EPS (Basic) | $1.12 | $0.92 | $1.05 | $0.88 | $1.50 | $0.55 | $0.20 | $0.38 | $0.23 | $-0.05 | $0.02 | $0.01 | $0.57 | $0.49 | $0.50 | $0.48 | |
| EPS (Diluted) | $1.10 | $0.90 | $1.01 | $0.88 | $1.49 | $0.54 | $0.19 | $0.38 | $0.23 | $-0.05 | $0.01 | $0.01 | $0.57 | $0.48 | $0.48 | $0.47 | |
| Shares (Basic) | 135,054,000 | 135,364,000 | · | 134,502,000 | 135,205,000 | 136,757,000 | · | 135,615,000 | 135,195,000 | 135,358,000 | · | 113,537,000 | 100,373,000 | 100,279,000 | · | 99,652,000 | |
| Shares (Diluted) | 137,384,000 | 138,191,000 | · | 135,394,000 | 136,499,000 | 139,774,000 | · | 138,062,000 | 136,979,000 | 135,358,000 | · | 115,245,000 | 101,782,000 | 102,196,000 | · | 101,417,000 | |
| EBITDA | $182M | $220M | · | $137M | $76M | $163M | · | $48M | $50M | $63M | · | $404.0K | $66M | $75M | · | $60M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $508M | $561M | $526M | · | · | · | $784M | · | · | · | · | · | · | · | · | · | |
| Short-term Investments | $87M | $69M | $31M | $19M | · | · | $106M | $72M | $83M | $80M | · | $189M | $306M | $287M | · | $271M | |
| Receivables | $692M | $686M | $679M | $619M | $612M | $535M | $558M | $588M | $612M | $534M | · | $494M | $240M | $223M | · | $206M | |
| Inventory | $811M | $773M | $759M | $772M | $772M | $664M | $659M | $718M | $770M | $816M | · | $905M | $336M | $321M | · | $282M | |
| Prepaid Expense | $70M | $60M | $65M | $74M | $68M | $47M | $50M | $51M | $46M | $43M | · | $48M | $20M | $19M | · | $24M | |
| Current Assets | $2.22B | $2.20B | $2.13B | $1.92B | $1.73B | $1.71B | $2.18B | $2.06B | $1.92B | $1.83B | · | $1.92B | $1.21B | $1.07B | · | $920M | |
| PP&E (Net) | $534M | $557M | $564M | $578M | $588M | $556M | $562M | $568M | $572M | $579M | · | $607M | $248M | $245M | · | $236M | |
| PP&E (Gross) | $1.30B | $1.30B | $1.27B | $1.22B | $1.19B | $1.13B | $1.11B | $1.07B | $1.05B | $1.03B | · | $995M | $612M | $599M | · | $569M | |
| Accum. Depreciation | $770M | $748M | $705M | $647M | $602M | $572M | $546M | $506M | $480M | $447M | · | $388M | $364M | $354M | · | $333M | |
| Goodwill | $1.44B | $1.44B | $1.44B | $1.43B | $1.43B | $1.43B | $1.43B | $1.43B | $1.45B | $1.45B | $1.43B | $1.12B | $199M | $199M | $197M | $182M | |
| Intangibles | $693M | $721M | $745M | $774M | $796M | $772M | $795M | $843M | $867M | $888M | · | $1.26B | $55M | $59M | · | $54M | |
| Other Non-current Assets | $79M | $79M | $79M | $77M | $75M | $75M | $75M | $77M | $78M | $78M | · | $69M | $47M | $45M | · | $36M | |
| Total Assets | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B | |
| Accounts Payable | $107M | $104M | $99M | $87M | $87M | $73M | $75M | $58M | $67M | $50M | · | $87M | $34M | $40M | · | $32M | |
| Accrued Liabilities | $301M | $313M | $334M | $326M | $282M | $238M | $261M | $255M | $216M | $210M | · | $222M | $90M | $84M | · | $88M | |
| Current Liabilities | $479M | $482M | $498M | $466M | $425M | $385M | $856M | $818M | $794M | $786M | · | $429M | $155M | $168M | · | $145M | |
| Capital Leases | $97M | $100M | $104M | $105M | $108M | $82M | $84M | $86M | $88M | $90M | · | $100M | · | · | · | · | |
| Deferred Tax | · | · | · | $23M | $24M | $47M | · | $7M | $27M | $40M | · | $132M | $5M | $1M | · | $2M | |
| Other Non-current Liabilities | $19M | $21M | $21M | $25M | $22M | $25M | $22M | $23M | $25M | $24M | · | $22M | $14M | $13M | · | $13M | |
| Total Liabilities | $720M | $707M | $730M | $697M | $665M | $623M | $1.07B | $1.02B | $1.02B | $1.02B | · | $1.17B | $227M | $235M | · | $212M | |
| Paid-in Capital | $3.23B | $3.21B | $3.17B | $3.10B | $3.07B | $3.05B | $3.03B | $2.95B | $2.91B | $2.89B | · | $2.86B | $657M | $645M | · | $606M | |
| Retained Earnings | $1.53B | $1.51B | $1.39B | $1.29B | $1.21B | $1.04B | $1.15B | $1.13B | $1.07B | $1.05B | · | $1.35B | $1.35B | $1.29B | · | $1.19B | |
| AOCI | $11M | $14M | $15M | $11M | $10M | $-2M | $-7M | $-7M | $-12M | $-11M | · | $-19M | $-19M | $-19M | · | $-32M | |
| Stockholders' Equity | $4.77B | $4.73B | $4.57B | $4.40B | $4.30B | $4.09B | $4.18B | $4.07B | $3.98B | $3.92B | $4.00B | $4.19B | $1.99B | $1.91B | $1.85B | $1.76B | |
| Liabilities + Equity | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $69M | $70M | $69M | $71M | $71M | $66M | $68M | $67M | $64M | $55M | $72M | $37M | $18M | $18M | $17M | $18M | |
| Stock-based Comp | $13M | $13M | $11M | $12M | $14M | $13M | $12M | $12M | $13M | $17M | $12M | $23M | $9M | $9M | $9M | $8M | |
| Amort. of Intangibles | $30M | $30M | $29M | $30M | $30M | $29M | $30M | $30M | $30M | $30M | $28M | $14M | $5M | $5M | $5M | $4M | |
| Restructuring | · | · | · | · | · | $154.0K | · | $6M | $-488.0K | $24M | · | · | · | · | · | · | |
| Other Non-cash | · | $-4M | · | · | · | $23M | · | · | · | $-13M | · | · | · | $-23M | · | · | |
| Operating Cash Flow | $210M | $202M | $249M | $250M | $78M | $177M | $210M | $204M | $54M | $52M | $105M | $50M | $35M | $53M | $64M | $33M | |
| CapEx | $33M | $40M | $46M | $36M | $47M | $36M | $17M | $42M | $28M | $29M | $23M | $22M | $18M | $16M | $18M | $12M | |
| Investing Cash Flow | $-129M | $-183M | $-111M | $-76M | $-299M | $131M | $-104M | $-15M | $-10M | $-47M | $321M | $-81M | $52M | $11M | $-60M | $-63M | |
| Stock Repurchased | $136M | $0 | $45M | $40M | $25M | $190M | $1M | $0 | $1M | $83M | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-190M | · | · | · | $-83M | · | · | · | · | · | · | |
| Financing Cash Flow | $-134M | $18M | $13M | $-32M | $-25M | $-635M | $60M | $20M | $9M | $-116M | $-237M | $1M | $1M | $3M | $14M | $13M | |
| Net Change in Cash | $-53M | $35M | $154M | $142M | $-232M | $-323M | $162M | $212M | $56M | $-113M | $188M | $-27M | $89M | $67M | $16M | $-17M | |
| Taxes Paid | $25M | $6M | $4M | $2M | $86M | $7M | $41M | $46M | $70M | $2M | $35M | $26M | $37M | $2M | $20M | $22M | |
| Free Cash Flow | · | $163M | · | · | · | $141M | · | · | · | $24M | · | · | · | $37M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 58.7% | 60.2% | · | 64.7% | 73.8% | 74.4% | · | 74.2% | |
| Operating Margin | 23.1% | 19.8% | · | 17.9% | 10.2% | 16.2% | · | 7.7% | 7.9% | 1.3% | · | 0.11% | 22.7% | 20.4% | · | 23.5% | |
| Net Margin | 19.2% | 16.4% | · | 15.5% | 27.2% | 12.6% | · | 8.3% | 5.0% | -1.2% | · | 0.26% | 19.8% | 17.8% | · | 18.7% | |
| Pretax Margin | 24.0% | 20.7% | · | 18.7% | 25.2% | 17.3% | · | 9.1% | 7.6% | -1.4% | · | 0.66% | 25.6% | 22.8% | · | 24.2% | |
| EBITDA Margin | 23.1% | 29.0% | · | 17.9% | 10.2% | 27.3% | · | 7.7% | 7.9% | 10.4% | · | 0.11% | 22.7% | 26.9% | · | 23.5% | |
| ROA | 2.9% | 2.5% | · | 2.3% | 4.1% | 1.6% | · | 0.99% | 0.88% | -0.20% | · | 0.03% | 2.8% | 2.4% | · | 2.4% | |
| ROE | 3.3% | 2.8% | · | 2.8% | 4.9% | 1.9% | · | 1.3% | 1.1% | -0.24% | · | 0.03% | 3.1% | 2.7% | · | 2.7% | |
| ROIC | 3.0% | 2.5% | · | 2.6% | 1.9% | 1.7% | · | 1.1% | 0.83% | 0.17% | · | 0.00% | 2.6% | 2.3% | · | 2.6% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 4.6 | · | 4.1 | 4.1 | 4.4 | · | 2.5 | 2.4 | 2.3 | · | 4.5 | 7.8 | 6.4 | · | 6.3 | |
| Quick Ratio | 2.7 | 2.7 | · | 1.4 | 1.4 | 1.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 3.5 | 3.0 | · | 3.3 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.5 | 0.4 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.1 | · | 1.2 | 1.5 | 1.6 | · | 1.1 | 1.3 | 1.4 | · | 1.4 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $5.75 | $5.50 | · | $5.68 | $5.46 | $4.28 | · | $4.53 | $4.60 | $4.48 | · | $3.33 | $2.87 | $2.71 | · | $2.51 | |
| Cash Flow / Share | · | $1.46 | · | · | · | $1.27 | · | · | · | $0.39 | · | · | · | $0.52 | · | · | |
| EPS (TTM) | $3.89 | $4.28 | · | $3.10 | $2.60 | $1.34 | · | $0.57 | $0.20 | $0.54 | · | $1.54 | $2.00 | $1.96 | · | $1.52 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.14B | $3.10B | · | $2.77B | $2.63B | $2.51B | · | $2.48B | $2.24B | $1.90B | · | $1.23B | $1.10B | $1.07B | · | $998M | |
| Net Income TTM | $535M | $587M | · | $424M | $357M | $186M | · | $92M | $41M | $67M | · | $158M | $204M | $201M | · | $155M | |
| P/E | 20.3 | 20.1 | · | 18.5 | 22.7 | 54.6 | · | 125.5 | 342.4 | 99.3 | · | 32.2 | 29.8 | 28.9 | · | 39.2 | |
| Earnings Yield | 4.9% | 5.0% | · | 5.4% | 4.4% | 1.8% | · | 0.80% | 0.29% | 1.0% | · | 3.1% | 3.4% | 3.5% | · | 2.5% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $2.94B | $2.52B | $1.57B | $1.02B | $958M |
| Margem Bruta % | · | · | 65.0% | · | 75.0% |
| Margem Operacional % | 16.3% | 6.6% | 8.5% | · | 17.9% |
| Lucro líquido | $538M | $103M | $123M | $190M | $149M |
| EPS Diluído | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 4.3 | 2.5 | 4.9 | · | 6.2 |
| Índice de Liquidez Seca | 2.5 | 0.8 | 1.4 | · | 3.0 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $589M | $405M | $165M | · | $219M |
Investidores institucionais (13F) 639 declarantes · $10.4B total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
639
Valor detido
$10.4B
Novas posições
76
Posições encerradas
82
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 76 (-42 vs trimestre anterior) | 82 (+32 vs trimestre anterior) | 254 (+26 vs trimestre anterior) | 180 (0 vs trimestre anterior) | +5.4M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $921.072.916 | 10.549.455 | 8,82% | Ações |
| BlackRock, Inc. | $853.839.261 | 10.806.724 | 8,18% | Ações |
| JANUS HENDERSON GROUP PLC | $656.831.032 | 7.623.095 | 6,29% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $403.546.103 | 5.107.532 | 3,86% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $394.606.359 | 4.994.385 | 3,78% | Ações |
| Invesco Ltd. | $340.515.006 | 4.309.771 | 3,26% | Ações |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $338.141.467 | 4.279.730 | 3,24% | Ações |
| STATE STREET CORP | $293.540.630 | 3.714.029 | 2,81% | Ações |
| Sculptor Capital LP | $237.030.000 | 3.000.000 | 2,27% | Ações |
| JPMORGAN CHASE & CO | $230.761.440 | 2.743.850 | 2,21% | Ações |
| Burgundy Asset Management Ltd. | $212.054.428 | 3.460.983 | 2,03% | Ações |
| ALLIANCEBERNSTEIN L.P. | $205.090.439 | 2.380.344 | 1,96% | Ações |
| BANK OF MONTREAL /CAN/ | $191.638.042 | 2.425.491 | 1,83% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $187.250.224 | 2.369.310 | 1,79% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $170.151.584 | 2.153.014 | 1,63% | Ações |
| GOLDMAN SACHS GROUP INC | $140.764.853 | 1.781.608 | 1,35% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $135.630.225 | 1.716.621 | 1,30% | Ações |
| Boston Trust Walden Corp | $124.311.253 | 1.573.361 | 1,19% | Ações |
| Boston Partners | $122.847.510 | 1.554.990 | 1,18% | Ações |
| Allspring Global Investments Holdings, LLC | $119.384.889 | 1.571.681 | 1,14% | Ações |
| GENEVA CAPITAL MANAGEMENT LLC | $111.962.440 | 1.417.067 | 1,07% | Ações |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $101.519.633 | 1.284.896 | 0,97% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $98.471.901 | 1.246.322 | 0,94% | Ações |
| Quantinno Capital Management LP | $96.320.933 | 1.219.098 | 0,92% | Ações |
| NORGES BANK | $89.048.300 | 1.127.051 | 0,85% | Ações |
| FULLER & THALER ASSET MANAGEMENT, INC. | $88.055.393 | 1.114.484 | 0,84% | Ações |
| MORGAN STANLEY | $86.496.544 | 1.094.753 | 0,83% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $84.736.329 | 1.072.476 | 0,81% | Ações |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $81.207.111 | 1.027.808 | 0,78% | Ações |
| WELLS FARGO & COMPANY/MN | $78.742.680 | 996.617 | 0,75% | Ações |
| Madison Avenue Partners, LP | $73.891.416 | 935.216 | 0,71% | Ações |
| ANTIPODES PARTNERS Ltd | $71.581.796 | 905.984 | 0,69% | Ações |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $70.042.286 | 886.499 | 0,67% | Ações |
| NORTHERN TRUST CORP | $69.578.813 | 880.633 | 0,67% | Ações |
| AXA Investment Managers S.A. | $68.885.959 | 1.202.828 | 0,66% | Ações |
| Global Alpha Capital Management Ltd. | $67.681.230 | 856.616 | 0,65% | Ações |
| Vestal Point Capital, LP | $67.158.500 | 850.000 | 0,64% | Ações |
| UBS Group AG | $65.909.432 | 834.191 | 0,63% | Ações |
| Bank of New York Mellon Corp | $61.258.598 | 775.328 | 0,59% | Ações |
| FMR LLC | $60.683.705 | 768.051 | 0,58% | Ações |
| BANK OF AMERICA CORP /DE/ | $58.239.298 | 737.113 | 0,56% | Ações |
| Stephens Investment Management Group LLC | $57.159.864 | 723.451 | 0,55% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $56.575.822 | 716.059 | 0,54% | Ações |
| RAYMOND JAMES FINANCIAL INC | $54.970.813 | 695.745 | 0,53% | Ações |
| Clark Capital Management Group, Inc. | $54.271.890 | 686.899 | 0,52% | Ações |
| AMERICAN CAPITAL MANAGEMENT INC | $51.599.219 | 653.072 | 0,49% | Ações |
| ANCHOR CAPITAL ADVISORS LLC | $51.225.201 | 648.338 | 0,49% | Ações |
| Camber Capital Management LP | $47.216.000 | 800.000 | 0,45% | Ações |
| Capital World Investors | $46.664.254 | 590.612 | 0,45% | Ações |
| Artemis Investment Management LLP | $45.305.914 | 573.420 | 0,43% | Ações |
Executivos da empresa 22 insiders · 11 diretores · 15 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Keith W Pfeil | President, CEO | 21 de Janeiro de 2026 A | 0 | 0 | 0 | $0 |
| Daniel T Scavilla | President, CEO | 23 de Janeiro de 2025 A | 0 | 0 | 0 | $0 |
| David M Demski | President, CEO | 27 de Janeiro de 2022 A | 0 | 0 | 0 | $0 |
| Kyle Kline | Senior Vice President, CFO | 21 de Janeiro de 2026 A | 0 | 0 | 2 | $-2.032.133 |
| Richard A Baron | Senior VP and CFO | 2 de Maio de 2014 M | 0 | 0 | 0 | $0 |
| Anthony L Williams | President | 7 de Março de 2019 M | 0 | 0 | 0 | $0 |
| Kelly Huller | EVP, GC, Corporate Secretary | 25 de Fevereiro de 2026 M | 0 | 0 | 3 | $-3.441.700 |
| David C Paul | Executive Chairman | 21 de Janeiro de 2026 A | 60.417 | 0 | 0 | $0 |
| Steven Payne | Chief Accounting Officer | 1 de Fevereiro de 2019 A | 0 | 0 | 0 | $0 |
| Eric Schwartz | Senior VP and General Counsel | 25 de Junho de 2018 M | 0 | 0 | 0 | $0 |
| Brett A Murphy | EVP, International Sales | 2 de Fevereiro de 2018 A | 35.217 | 0 | 0 | $0 |
| James R Tobin | Conselheiro | 15 de Setembro de 2026 M | 0 | 0 | 1 | $-2.237.400 |
| Stephen T Zarrilli | Conselheiro | 18 de Agosto de 2026 M | 0 | 0 | 2 | $-4.283.250 |
| David D Davidar | Conselheiro | 27 de Julho de 2026 G | 507.675 | 0 | 2 | $-4.169.000 |
| Ann D Rhoads | Conselheiro | 4 de Junho de 2026 M | 40.384 | 0 | 2 | $-818.000 |
| Dan Wolterman | Conselheiro | 21 de Janeiro de 2026 A | 24.025 | 0 | 0 | $0 |
| Leslie V Norwalk | Conselheiro | 21 de Janeiro de 2026 A | 10.419 | 0 | 2 | $-557.600 |
| Dan Lemaitre | Conselheiro | 21 de Janeiro de 2026 A | 0 | 0 | 0 | $0 |
| John A Deford | Conselheiro | 21 de Janeiro de 2026 A | 15.578 | 0 | 0 | $0 |
| Robert Andrew Douglas | Conselheiro | 21 de Janeiro de 2026 A | 2.005 | 0 | 0 | $0 |
| Kurt Wheeler | Conselheiro | 22 de Janeiro de 2019 A | 44.319 | 0 | 0 | $0 |
| Robert Liptak | Conselheiro | 22 de Janeiro de 2019 A | 26.159 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 69 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 2,90% | 16.797 NS | 31 de Julho de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,26% | 300.351 NS | 31 de Julho de 2026 | N-PORT |
| GRPM · Invesco Exchange-Traded Fund Trust | 1,83% | 122.008 SH | 2 de Outubro de 2026 | Diário |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,52% | 13.339 NS | 31 de Julho de 2026 | N-PORT |
| BUL · Pacer Funds Trust | 1,37% | 22.796 NS | 31 de Julho de 2026 | N-PORT |
| ROBO · EXCHANGE TRADED CONCEPTS TRUST | 1,35% | 340.460 NS | 31 de Julho de 2026 | N-PORT |
| IHI · iShares Trust | 1,25% | 541.723 SH | 11 de Setembro de 2026 | Diário |
| RFG · Invesco Exchange-Traded Fund Trust | 0,81% | 36.501 SH | 2 de Outubro de 2026 | Diário |
| MCOW · Pacer Funds Trust | 0,68% | 92 NS | 31 de Julho de 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,58% | 9.542 NS | 31 de Julho de 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 0,50% | 13.493 SH | 2 de Outubro de 2026 | Diário |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,47% | 111.810 SH | 19 de Agosto de 2026 | Diário |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,34% | 20.104 NS | 31 de Julho de 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,32% | 23.234 NS | 31 de Julho de 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,30% | 16.476 SH | 2 de Outubro de 2026 | Diário |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,29% | 16.839 NS | 31 de Julho de 2026 | N-PORT |
| ISCG · iShares Trust | 0,28% | 35.968 SH | 11 de Setembro de 2026 | Diário |
| BKMC · BNY Mellon ETF Trust | 0,27% | 22.533 NS | 31 de Julho de 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,25% | 12.456 NS | 31 de Julho de 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,25% | 183.180 SH | 19 de Agosto de 2026 | Diário |
| VBK · VANGUARD INDEX FUNDS | 0,24% | 1.499.816 SH | 19 de Agosto de 2026 | Diário |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,19% | 49.674 NS | 31 de Julho de 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,19% | 1.664 NS | 31 de Julho de 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,18% | 57.770 NS | 31 de Julho de 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,15% | 284.148 NS | 31 de Julho de 2026 | N-PORT |
| IYH · iShares Trust | 0,13% | 65.761 SH | 11 de Setembro de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,13% | 338.547 SH | 19 de Agosto de 2026 | Diário |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,13% | 22.085 SH | 2 de Outubro de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,13% | 53.700 NS | 31 de Julho de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,13% | 245.718 NS | 31 de Julho de 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 0,12% | 39.173 NS | 31 de Julho de 2026 | N-PORT |
| SMMD · iShares Trust | 0,11% | 59.918 SH | 11 de Setembro de 2026 | Diário |
| VB · VANGUARD INDEX FUNDS | 0,11% | 2.596.850 SH | 19 de Agosto de 2026 | Diário |
| VXF · VANGUARD INDEX FUNDS | 0,10% | 1.300.059 SH | 19 de Agosto de 2026 | Diário |
| VFMF · VANGUARD WELLINGTON FUND | 0,10% | 8.946 SH | 19 de Agosto de 2026 | Diário |
| DFSV · Dimensional ETF Trust | 0,10% | 103.731 NS | 31 de Julho de 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0,10% | 10.513 NS | 31 de Julho de 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 10.277 SH | 2 de Outubro de 2026 | Diário |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 6.977 NS | 31 de Julho de 2026 | N-PORT |
| IWS · iShares Trust | 0,08% | 166.482 SH | 11 de Setembro de 2026 | Diário |
| WSML · iShares Trust | 0,08% | 6.832 SH | 11 de Setembro de 2026 | Diário |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,07% | 13.036 NS | 31 de Julho de 2026 | N-PORT |
| IWR · iShares Trust | 0,06% | 458.676 SH | 11 de Setembro de 2026 | Diário |
| DFUV · Dimensional ETF Trust | 0,04% | 87.854 NS | 31 de Julho de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,04% | 2.717 NS | 31 de Julho de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,03% | 205.429 NS | 31 de Julho de 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,03% | 20.026 SH | 2 de Outubro de 2026 | Diário |
| DFSU · Dimensional ETF Trust | 0,03% | 8.925 NS | 31 de Julho de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,03% | 11.916 NS | 31 de Julho de 2026 | N-PORT |
| IUSG · iShares Trust | 0,02% | 99.439 SH | 11 de Setembro de 2026 | Diário |
| IWD · iShares Trust | 0,02% | 248.750 SH | 11 de Setembro de 2026 | Diário |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 67.710 SH | 19 de Agosto de 2026 | Diário |
| ESGV · VANGUARD WORLD FUND | 0,02% | 25.284 SH | 19 de Agosto de 2026 | Diário |
| DFAU · Dimensional ETF Trust | 0,02% | 27.167 NS | 31 de Julho de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 38.185 NS | 31 de Julho de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 3.476 NS | 31 de Julho de 2026 | N-PORT |
| IYY · iShares Trust | 0,01% | 4.949 SH | 11 de Setembro de 2026 | Diário |
| IWB · iShares Trust | 0,01% | 77.825 SH | 11 de Setembro de 2026 | Diário |
| PRF · Invesco Exchange-Traded Fund Trust | 0,01% | 15.270 SH | 2 de Outubro de 2026 | Diário |
| ITOT · iShares Trust | 0,01% | 145.193 SH | 11 de Setembro de 2026 | Diário |
| IWV · iShares Trust | 0,01% | 30.738 SH | 11 de Setembro de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3.596.212 SH | 19 de Agosto de 2026 | Diário |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 89.702 SH | 19 de Agosto de 2026 | Diário |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 18.804 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9.508 SH | 19 de Agosto de 2026 | Diário |
| IJH · iShares Trust | · | 3.976.473 SH | 11 de Setembro de 2026 | Diário |
| IJK · iShares Trust | · | 657.157 SH | 11 de Setembro de 2026 | Diário |
| XJH · iShares Trust | · | 15.479 SH | 8 de Setembro de 2026 | Diário |
| ISCB · iShares Trust | · | 5.094 SH | 11 de Setembro de 2026 | Diário |
GMED Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 23 analistas
COMPRA
Alvo mediano
$100.00
+32,3%
4 17,4%
Compra forte
12 52,2%
Compra
7 30,4%
Manter
0 0,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
13 analistas · 2026-10-03Alvo médio $100.92 +33,5%
← Abaixo de todos os alvos
Preço atual $75.60
Mín$84.00
Média$100.92
Máx$125.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| TFX | · | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| ITGR | $2.69B | 27.1 | 8.0% | 5.5% | 6.0% | 27.0% |
| NVST | $3.56B | 77.5 | 8.3% | 1.7% | 1.5% | 54.7% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Sinais de trading Sinais recentes de compra/venda com preço de entrada e relação risco/recompensa
BLUECHIP_DIP
Stop out
risco 1
recompensa 1,71
entrada
$80.54
R:R 1,71
BLUECHIP_DIP
Stop out
risco 1
recompensa 1,92
entrada
$79.89
R:R 1,92
BLUECHIP_DIP
Stop out
risco 1
recompensa 1,79
entrada
$82.29
R:R 1,79
Nenhum sinal aberto no momento — nenhum cartão está preenchido, e isso é honesto.
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Ago 6, 2026